泽璟制药：营收增速环比继续提高，TCE领域显优势
Zelgen(688266) 华安证券·2024-10-28 06:00泽璟制药（ [Table_StockNameRptType] 688266.SH） 公司点评 营收增速环比继续提高，TCE 领域显优势 | --- | --- | --- | |--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------|----------------------------------------------------------------------- ...